Defunct Company
Total Trials
10
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,291
NCT00083941
A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2004
Completion: Jul 31, 2008
NCT00325507
Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma
Start: Nov 30, 2005
NCT00358566
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Phase: Phase 3
Start: Jun 30, 2006
Completion: Aug 31, 2008
NCT01420159
Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma
Start: Aug 31, 2011
Completion: Jul 31, 2012
NCT01581450
Hyperalgesia and Pain
Phase: Phase 1
Start: Jan 31, 2012
Completion: Apr 30, 2012
NCT02243683
Safety Study of Immune System Modulator for Autoimmune Diseases
Start: Sep 30, 2014
Completion: Mar 31, 2015
NCT02572635
A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax
Start: Oct 31, 2015
Completion: Sep 30, 2016
NCT03077048
Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients
Phase: Phase 1/2
Start: Mar 30, 2017
Completion: May 2, 2018
NCT02869243
A Dose Escalation Phase I Study Of Human- Recombinant Bone Morphogenetic Protein 4 Administrated Via CED In GBM Patients
Start: Jul 18, 2017
Completion: Jun 30, 2021
NCT03661489
Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery
Start: Jul 24, 2018
Completion: Apr 2, 2020